SCHEMBL3887461

SCHEMBL3887461

OCCc1ccccc1SCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.55
TDP1 Q9NUW8 1/20 0.50
KMT2A Q03164 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PTPRC P08575 1/20 0.44
MEN1 O00255 1/20 0.42
HSD17B10 Q99714 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
HTT P42858 1/20 0.40
IDO1 P14902 3/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
TSHR P16473 1/20 0.38
PTGER1 P34995 1/20 0.38
PTGER4 P35408 1/20 0.38
PTGER3 P43115 1/20 0.38
PTGER2 P43116 1/20 0.38
ALDH1A1 P00352 1/20 0.37
MAOA P21397 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1903485 0.84 APOBEC3G (0.59) POLBTDP1KMT2AL3MBTL1PTPRC
SCHEMBL2045886 0.78 POLB (0.52) POLBKMT2AL3MBTL1PTPRCMEN1
SCHEMBL9507471 0.78 POLB (0.61) POLBKMT2AL3MBTL1PTPRCMEN1
SCHEMBL588785 0.77 APOBEC3G (0.48) TDP1APOBEC3GALDH1A1LMNA
SCHEMBL6638095 0.76 POLB (0.59) POLBKMT2AL3MBTL1PTPRCMEN1
SCHEMBL21315691 0.76 POLB (0.64) POLBKMT2AL3MBTL1PTPRCMEN1
SCHEMBL1902909 0.76 POLB (0.59) POLBTDP1KMT2AL3MBTL1PTPRC
SCHEMBL19260908 0.76 POLB (0.59) POLBKMT2AL3MBTL1PTPRCMEN1
SCHEMBL8631418 0.76 POLB (0.53) POLBTDP1KMT2AL3MBTL1PTPRC
SCHEMBL8960943 0.74 MTNR1A (0.52) KMT2AL3MBTL1MEN1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264660-A1 PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS Kang, Heonjoong (KR) 2009-10-22 US disclosed
US-20090264660-A1 PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS Kang, Heonjoong (KR) 2009-10-22 US disclosed
US-20090264660-A1 PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS Kang, Heonjoong (KR) 2009-10-22 US disclosed
EP-1812386-A1 PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS Kang, Heonjoong (KR) 2007-08-01 EP disclosed
WO-2006043797-A1 PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS KANG HEONJOONG (KR) 2006-04-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264660-A1 PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS TST, ARSA, STS POLB 3675/4885TDP1 4840/4885KMT2A 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.